San Francisco, CA, United States of America

Marc Awobuluyi


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Marc Awobuluyi

Introduction

Marc Awobuluyi is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the area of excitatory glycine receptors. With a total of 2 patents, his work has implications for both diagnostic and therapeutic methods.

Latest Patents

Marc's latest patents focus on excitatory glycine receptors and methods. The inventions provide isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Additionally, the patents include excitatory glycine receptors that contain either NR3B or NR3A polypeptides. The methods outlined in these patents are designed for detecting excitatory glycine receptor ligands, agonists, and antagonists. Furthermore, the inventions offer related diagnostic and therapeutic methods.

Career Highlights

Throughout his career, Marc has worked with esteemed institutions such as the Sanford-Burnham Medical Research Institute and Yale University. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Marc has collaborated with notable colleagues, including Stuart A. Lipton and Dongxian Zhang. These partnerships have enriched his work and expanded the impact of his inventions.

Conclusion

Marc Awobuluyi's contributions to the field of biotechnology through his patents on excitatory glycine receptors demonstrate his innovative spirit and commitment to advancing medical science. His work continues to influence research and therapeutic approaches in this important area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…